Dolby Laboratories, Inc.
DLBNYSEFinancials · Patent Owners & Lessors · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B | $1.16B |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M | $218.7M |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M | $310.2M | $231.4M |
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B |
| Total liabilities | $595.8M | $623.0M | $607.6M | $438.5M | $501.5M | $478.9M |
| Equity | $2.62B | $2.48B | $2.36B | $2.25B | $2.60B | $2.43B |
| EPS (diluted) | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 | $2.25 |
| Shares out. | 97.5M | 97.3M | 97.7M | 102.0M | 104.6M | 102.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 19.6%
- Net margin
- 18.9%
- Return on equity
- 9.7%
- Return on assets
- 7.9%
- Return on capital (ROCE)
- 9.5%
- Liabilities / assets
- 18.5%
- Debt / equity
- 0.23×
- Book value / share
- $26.90
- Revenue growth (YoY)
- 5.9%
- Net income growth (YoY)
- −2.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 9.77safe
- Accruals / assets
- −6.7%clean
- Beneish M-Score
- -2.77normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Morgan StanleyPassive (13G)May 11, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Bank Of New York Mellon CorpPassive (13G)Apr 28, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Dolby DagmarActivist (13D)Feb 13, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 4.6M | 4.3 | +7.7% |
| Apr 30, 2026 | 4.3M | 8.4 | +2.2% |
| Apr 15, 2026 | 4.2M | 7.9 | +6.6% |
| Mar 31, 2026 | 3.9M | 5.5 | +12.5% |
| Mar 13, 2026 | 3.5M | 5.9 | -1.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Other material eventApr 30, 2026
- Shareholder voteFeb 6, 2026
- Results of operations · Other material eventJan 29, 2026
- Results of operations · Other material eventNov 18, 2025
- Director / officer changeNov 14, 2025
- Results of operations · Other material eventJul 31, 2025
- Results of operations · Other material eventMay 1, 2025
- Amended charter or bylaws · Shareholder voteFeb 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.